Literature DB >> 26545981

Mouse hippocampal phosphorylation footprint induced by generalized seizures: Focus on ERK, mTORC1 and Akt/GSK-3 pathways.

Giuseppe Gangarossa1, Sophie Sakkaki2, Philippe Lory3, Emmanuel Valjent4.   

Abstract

Exacerbated hippocampal activity has been associated to critical modifications of the intracellular signaling pathways. We have investigated rapid hippocampal adaptive responses induced by maximal electroshock seizure (MES). Here, we demonstrate that abnormal and exacerbated hippocampal activity induced by MES triggers specific and temporally distinct patterns of phosphorylation of extracellular signal-related kinase (ERK), mammalian target of rapamycin complex (mTORC) and Akt/glycogen synthase kinase-3 (Akt/GSK-3) pathways in the mouse hippocampus. While the ERK pathway is transiently activated, the mTORC1 cascade follows a rapid inhibition followed by a transient activation. This rebound of mTORC1 activity leads to the selective phosphorylation of p70S6K, which is accompanied by an enhanced phosphorylation of the ribosomal subunit S6. In contrast, the Akt/GSK-3 pathway is weakly altered. Finally, MES triggers a rapid upregulation of several plasticity-associated genes as a consequence exacerbated hippocampal activity. The results reported in the present study are reminiscent of the one observed in other models of generalized seizures, thus defining a common molecular footprint induced by intense and aberrant hippocampal activities.
Copyright © 2015 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Akt/GSK-3; ERK1/2; immediate early genes; mTORC; seizures; signal transduction

Mesh:

Substances:

Year:  2015        PMID: 26545981     DOI: 10.1016/j.neuroscience.2015.10.051

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  7 in total

1.  A Genetic Model of Epilepsy with a Partial Alzheimer's Disease-Like Phenotype and Central Insulin Resistance.

Authors:  Suélen Santos Alves; Rui Milton Patrício da Silva Junior; Polianna Delfino-Pereira; Marilia Gabriella Alves Goulart Pereira; Israel Vasconcelos; Hanna Schwaemmle; Rodrigo Focosi Mazzei; Maiko Luiz Carlos; Enilza Maria Espreafico; Antônio Claudio Tedesco; Adriano Sebollela; Sebastião Sousa Almeida; José Antônio Cortes de Oliveira; Norberto Garcia-Cairasco
Journal:  Mol Neurobiol       Date:  2022-04-04       Impact factor: 5.682

Review 2.  mTOR and MAPK: from localized translation control to epilepsy.

Authors:  Helena F Pernice; Rico Schieweck; Michael A Kiebler; Bastian Popper
Journal:  BMC Neurosci       Date:  2016-11-17       Impact factor: 3.288

3.  Profiling the MAPK/ERK dependent and independent activity regulated transcriptional programs in the murine hippocampus in vivo.

Authors:  Nils Blüthgen; Mirjam van Bentum; Barbara Merz; Dietmar Kuhl; Guido Hermey
Journal:  Sci Rep       Date:  2017-03-28       Impact factor: 4.379

Review 4.  Unravelling the Role of Glycogen Synthase Kinase-3 in Alzheimer's Disease-Related Epileptic Seizures.

Authors:  Runxuan Lin; Nigel Charles Jones; Patrick Kwan
Journal:  Int J Mol Sci       Date:  2020-05-23       Impact factor: 5.923

5.  Bi-directional genetic modulation of GSK-3β exacerbates hippocampal neuropathology in experimental status epilepticus.

Authors:  Tobias Engel; Raquel Gómez-Sintes; Mariana Alves; Eva M Jimenez-Mateos; Marta Fernández-Nogales; Amaya Sanz-Rodriguez; James Morgan; Edward Beamer; Alberto Rodríguez-Matellán; Mark Dunleavy; Takanori Sano; Jesus Avila; Miguel Medina; Felix Hernandez; José J Lucas; David C Henshall
Journal:  Cell Death Dis       Date:  2018-09-20       Impact factor: 8.469

Review 6.  GSK-3β at the Intersection of Neuronal Plasticity and Neurodegeneration.

Authors:  Tomasz Jaworski; Ewa Banach-Kasper; Katarzyna Gralec
Journal:  Neural Plast       Date:  2019-05-02       Impact factor: 3.599

7.  Tau Phosphorylation in a Mouse Model of Temporal Lobe Epilepsy.

Authors:  Marianna Alves; Aidan Kenny; Gioacchino de Leo; Edward H Beamer; Tobias Engel
Journal:  Front Aging Neurosci       Date:  2019-11-12       Impact factor: 5.750

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.